Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: NE NONMETROPOLITAN AREA — September 2026
Nebraska science talent scarce even as broader hiring cools.
Life, Physical, and Social Science openings outnumber candidates at a 0.87 ratio even as statewide unemployment holds at 2.9%, with Regulatory Affairs advertised pay down significantly to $83,688 locally.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Science occupation candidate ratio: 0.87 — vs 1.4 candidates per opening statewide
- Nebraska unemployment rate: 2.9% — Unchanged since July 2026, 6th lowest nationally
- Nebraska biotech average salary: $82,040 — May 2026, below national biotech clusters
- Pharmaceutical manufacturing wage: $25.86/hr — Aug 2026, amid weakening mfg employment
Key takeaways
Nebraska's science talent pool is tighter than the headline rate suggests.
A 0.87 candidate-to-opening ratio in Life, Physical, and Social Science occupations sits well below the state's 1.4 overall ratio, signaling that credential-driven roles face genuine scarcity even as general hiring cools. Headcount plans built on the 2.9% unemployment figure risk underestimating time-to-fill for PhD-level scientists and regulatory specialists.
Regulatory Affairs pay is falling locally while scarcity intensifies nationally.
Metro advertised pay for Regulatory Affairs Specialist dropped significantly to $83,688 even as national VP-level regulatory compensation climbs toward $580K on acute talent shortages. The divergence may suggest Nebraska employers are filling junior-to-mid regulatory roles locally while routing senior regulatory strategy work to coastal hubs or outsourced expertise.
Clinical Research Associate pay is rising against a falling Research Scientist trend.
CRA advertised pay climbed to a metro median of $99,630, outpacing even the national median, while Research Scientist pay fell to $126,124 locally against a rising national figure. This split is consistent with clinical-stage activity holding up in the metro even as discovery-stage science roles soften or shift toward CRO partners.
Lower regional pay levels remain a build-local argument, with limits.
Pharmaceutical manufacturing wages average $25.86/hour and biotech salaries trail coastal clusters by a wide margin, supporting cost-based retention and build arguments over CDMO outsourcing. That advantage erodes quickly if science-occupation scarcity keeps pushing specialized hires toward out-of-state or contract alternatives.
Median advertised pay by role — NE NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $126,124 | $126,124 | Significant decline | $131,354 |
| Clinical Research Associate | $62,961 | $99,630 | $100,556 | Significant increase | $90,956 |
| Lab Technician | $38,899 | $44,308 | $46,356 | Significant decline | $47,402 |
| Regulatory Affairs Specialist * | $67,140 | $83,688 | $108,488 | Significant decline | $104,000 |
| Clinical Data Manager * | $117,318 | $117,439 | $117,439 | Significant increase | $123,031 |
| Biostatistician * | $92,678 | $121,195 | $136,997 | Significant decline | $133,322 |
| Validation Engineer * | $78,870 | $80,220 | $80,220 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Nebraska's nonmetro labor market holds near full employment, with statewide unemployment flat at 2.9% through August, but the headline rate masks a tightening squeeze in science occupations specifically — Life, Physical, and Social Science openings now outnumber candidates, a 0.87 applicant-to-opening ratio versus 1.4 candidates per opening statewide. Slowing manufacturing employment and softer overall labor demand are giving general hiring some breathing room, even as credentialed scientific talent remains structurally scarce.
What it means
Nebraska's scientific labor pool is thin enough that even modest R&D or quality headcount additions compete directly against a shrinking candidate base, while broader labor market cooling does little to ease pressure in these specific job families. Lower regional pay levels (biotech averaging $82,040 versus national premiums for comparable roles) support a build-local retention argument, but only if compensation keeps pace with the tighter 0.87 candidate ratio rather than tracking the cooler headline unemployment rate. Consider benchmarking science-occupation offers against the Life/Physical/Social Science labor pool specifically, not against Nebraska's broader 2.9% unemployment backdrop.
Looking ahead
Expected: Nebraska Department of Labor releases official September 2026 employment data October 20, the first chance to confirm whether science-occupation tightness is deepening or easing against the cooling broader labor market.
Emerging pressure point: Manufacturing employment continues weakening statewide even as pharmaceutical manufacturing wages hold near $25.86/hour; watch whether softening industrial employment pushes transferable manufacturing talent toward biotech and device production lines.
Worth watching: Validation Engineer advertised pay sits flat locally at $80,220 against a moderate national rise to $108,377 — a widening gap that may test whether quality and manufacturing support roles stay competitive enough to avoid losing candidates to remote or out-of-state postings.
Potential inflection point: Nebraska's new state WARN Act (effective July 17) requires 90-day notice for mass layoffs affecting 100+ employees; any life sciences-adjacent filing would be an early, visible signal of restructuring risk in a labor pool already short on specialized talent.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.